Literature DB >> 20514357

The Role of Assertive Community Treatment in the Treatment of People with Borderline Personality Disorder.

Marcela Horvitz-Lennon1, Sarah Reynolds, Randy Wolbert, Thomas F Witheridge.   

Abstract

It is known that Assertive Community Treatment (ACT) is being used to treat people with borderline personality disorder (BPD), a puzzling trend given the lack of empirical support for this practice and the consensus that reserving ACT for a carefully selected population is critical to the sustainability of this costly intervention. Little is known about the contributors to this phenomenon and the ways in which ACT programs have adapted to the influx of patients with BPD. Many ACT programs in the US and Canada have integrated Dialectical Behavioral Therapy into the regular ACT programming, a practice that also lacks rigorous evidence of effectiveness. We provide a framework for policy-makers to decide on the optimal role of ACT in the continuum of care for people with BPD, and offer policy recommendations to address this phenomenon. There is an urgent need to generate the missing evidence and to improve and expand the services available to people with BPD, particularly those who are now being treated on ACT programs.

Entities:  

Year:  2009        PMID: 20514357      PMCID: PMC2877283          DOI: 10.1080/15487760903066446

Source DB:  PubMed          Journal:  Am J Psychiatr Rehabil        ISSN: 1548-7776


  28 in total

Review 1.  Cognitive behavior therapy for schizophrenia.

Authors:  Douglas Turkington; David Kingdon; Peter J Weiden
Journal:  Am J Psychiatry       Date:  2006-03       Impact factor: 18.112

2.  Schema therapy for borderline personality disorder.

Authors:  Scott H Kellogg; Jeffrey E Young
Journal:  J Clin Psychol       Date:  2006-04

3.  Cost-effectiveness of assertive community treatment teams.

Authors:  S M Essock; L K Frisman; N J Kontos
Journal:  Am J Orthopsychiatry       Date:  1998-04

4.  Functional impairment in patients with schizotypal, borderline, avoidant, or obsessive-compulsive personality disorder.

Authors:  Andrew E Skodol; John G Gunderson; Thomas H McGlashan; Ingrid R Dyck; Robert L Stout; Donna S Bender; Carlos M Grilo; M Tracie Shea; Mary C Zanarini; Leslie C Morey; Charles A Sanislow; John M Oldham
Journal:  Am J Psychiatry       Date:  2002-02       Impact factor: 18.112

5.  A guide to benefit-cost analysis, as seen through a controlled experiment in treating the mentally ill.

Authors:  B A Weisbrod
Journal:  J Health Polit Policy Law       Date:  1983       Impact factor: 2.265

Review 6.  Economic impacts of assertive community treatment: a review of the literature.

Authors:  E A Latimer
Journal:  Can J Psychiatry       Date:  1999-06       Impact factor: 4.356

Review 7.  Models of community care for severe mental illness: a review of research on case management.

Authors:  K T Mueser; G R Bond; R E Drake; S G Resnick
Journal:  Schizophr Bull       Date:  1998       Impact factor: 9.306

8.  Axis I comorbidity of borderline personality disorder.

Authors:  M C Zanarini; F R Frankenburg; E D Dubo; A E Sickel; A Trikha; A Levin; V Reynolds
Journal:  Am J Psychiatry       Date:  1998-12       Impact factor: 18.112

9.  Evaluating three treatments for borderline personality disorder: a multiwave study.

Authors:  John F Clarkin; Kenneth N Levy; Mark F Lenzenweger; Otto F Kernberg
Journal:  Am J Psychiatry       Date:  2007-06       Impact factor: 18.112

Review 10.  Advances in psychotherapy of personality disorders: a research update.

Authors:  Shelley McMain; Alberta E Pos
Journal:  Curr Psychiatry Rep       Date:  2007-02       Impact factor: 8.081

View more
  2 in total

1.  Utilization of evidenced based dialectical behavioral therapy in assertive community treatment: examining feasibility and challenges.

Authors:  Tracee Burroughs; Jacqueline Somerville
Journal:  Community Ment Health J       Date:  2012-02-14

2.  The connections place: a job preparedness program for individuals with borderline personality disorder.

Authors:  Beth Elliott; Richard J Konet
Journal:  Community Ment Health J       Date:  2013-02-14
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.